Shows & Panels
- AFCEA Answers
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Connected Government
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Cyber Imperative
- Cyber Solutions for 2013 and Beyond
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Mission-critical Apps in the Cloud
- The Path from Legacy Systems
- The Real Deal on Digital Government
- The Reality of Continuous Monitoring... Is Your Agency Secure?
- Veterans in Private Sector: Making the Transition
Shows & Panels
Va AG announces settlement with pharmaceutical
Thursday - 2/28/2013, 5:10am EST
RICHMOND, Va. (AP) -- Virginia's Medicaid program will receive more than $223,000 under a settlement that resolves allegations that a Texas-based company submitted false claims for an unapproved drug.
Attorney General Ken Cuccinelli announced the settlement Wednesday.
In December, the U.S. Justice Department said Healthpoint Ltd. and DFB Pharmaceuticals will pay up to $48 million to settle allegations that Healthpoint marketed a prescription skin ointment without approval from federal regulators. Several states worked with the Justice Department on the investigation.
The Justice Department said Healthpoint caused false claims for reimbursement to be submitted for Xenaderm, which is used for treating nursing home patients' bed sores. Fort Worth, Texas-based Healthpoint is one of DFB's operating companies.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.